STOCK TITAN

Arteris, Inc. (AIP) Financials

AIP
Trailing 12 months to June 30, 2026
Revenue $84.6M +33.8% YoY
Net Income -$39.5M -19.2% YoY
EPS (Diluted) -$0.87 -6.1% YoY
Free Cash Flow $6.8M +486.2% YoY
Market Cap $1.2B as of Oct 3, 2026
Price / Sales 14.3x on $84.6M revenue, trailing 12 months to June 30, 2026
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026
Price / Book 17.9x on $67.7M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AIP SEC filings page.

Arteris, Inc. (AIP) reported $84.6M in revenue over the twelve months to Jun 30, 2026, up 33.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AIP FY2025

Revenue is scaling, but persistent operating losses and negative equity show growth has not yet funded itself.

From FY2024 to FY2025, revenue increased to $70.6M while the operating loss remained $33.1M, so added sales have not yet translated into proportionate operating improvement. FY2025 operating cash flow reached $6.7M despite a net loss of $34.7M, revealing a sharp cash-versus-earnings split rather than self-funded profitability.

Gross margin stayed around 90%, but R&D consumed about 70.7% of FY2025 revenue, leaving a structurally heavy investment burden. The improvement in net margin from -58.3% in FY2024 to -49.2% in FY2025 shows losses are narrowing relative to sales, but not disappearing.

By FY2025, liabilities exceeded assets and negative equity reached -$14.6M, so the balance sheet is no longer supported by book net assets. The current ratio fell from 2.5x in FY2021 to 1.1x in FY2025, indicating a much thinner short-term cushion.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 68 / 100
Financial Health Score 68/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Arteris, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
86

Arteris, Inc. held $59.5M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations generated $6.7M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Arteris, Inc. scores 86/100 among other emerging companies.

Dilution
49

Arteris, Inc. had 45M shares outstanding at the end of fiscal year 2025, against 41M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Arteris, Inc. scores 49/100 among other emerging companies.

R&D Intensity
76

Arteris, Inc. spent $49.9M on research and development in fiscal year 2025, which was 48.1% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Arteris, Inc. scores 76/100 among other emerging companies.

Revenue Progress
60

Arteris, Inc. reported revenue of $70.6M in fiscal year 2025, against $57.7M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Arteris, Inc. scores 60/100 among other emerging companies.

Burn Trend
92

Arteris, Inc.'s operations generated $6.7M of cash in fiscal year 2025, against $720K used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Arteris, Inc. scores 92/100 among other emerging companies.

Balance Sheet
42

Arteris, Inc.'s cash, cash equivalents and investments came to $59.5M at the end of fiscal year 2025, against $129.7M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Arteris, Inc. scores 42/100 among other emerging companies.

Altman Z-Score Safe
3.28

Arteris, Inc. scores 3.28, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($1.2B) relative to total liabilities ($129.7M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
5/8

Arteris, Inc. passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Mixed
N/A

Arteris, Inc. reported a net loss of $34.7M while generating $6.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Arteris, Inc. reported an operating loss of $33.1M against $193K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$24.1M
YoY+46.2%
QoQ+5.2%
5Y CAGR+17.4%

Arteris, Inc. generated $24.1M in revenue in Q2 2026. This represents an increase of 46.2% from the same quarter a year earlier. Against the prior quarter it is up 5.2%.

EBITDA
-$12.4M
YoY-67.4%
QoQ-55.8%

Arteris, Inc.'s EBITDA was -$12.4M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 67.4% from the same quarter a year earlier. Against the prior quarter it is down 55.8%.

Net Income
-$14.1M
YoY-54.1%
QoQ-76.7%

Arteris, Inc. reported -$14.1M in net income in Q2 2026. This represents a decrease of 54.1% from the same quarter a year earlier. Against the prior quarter it is down 76.7%.

EPS (Diluted)
-$0.30
YoY-36.4%
QoQ-76.5%

Arteris, Inc. earned -$0.30 per diluted share (EPS) in Q2 2026. This represents a decrease of 36.4% from the same quarter a year earlier. Against the prior quarter it is down 76.5%.

Cash & Balance Sheet

Free Cash Flow
$8.6M
YoY+403.3%
QoQ+217.1%

Arteris, Inc. generated $8.6M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 403.3% from the same quarter a year earlier. Against the prior quarter it is up 217.1%.

Cash & Debt
$93.3M
YoY+479.3%
QoQ+699.0%
5Y CAGR+44.5%

Arteris, Inc. held $93.3M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding
49M
YoY+15.2%
QoQ+6.5%

Arteris, Inc. had 49M shares outstanding in Q2 2026. This represents an increase of 15.2% from the same quarter a year earlier. Against the prior quarter it is up 6.5%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin
85.0%
YoY-4.4pp
QoQ-0.8pp
5Y change-6.9pp

Arteris, Inc.'s gross margin was 85.0% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 4.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.

Operating Margin
-57.6%
YoY-7.7pp
QoQ-17.1pp
5Y change-25.1pp

Arteris, Inc.'s operating margin was -57.6% in Q2 2026, reflecting core business profitability. This is down 7.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 17.1 percentage points.

Net Margin
-58.3%
YoY-2.9pp
QoQ-23.6pp
5Y change-22.1pp

Arteris, Inc.'s net profit margin was -58.3% in Q2 2026, showing the share of revenue converted to profit. This is down 2.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 23.6 percentage points.

Return on Equity
-20.8%
QoQ+286.4pp

Arteris, Inc.'s ROE was -20.8% in Q2 2026, measuring profit generated per dollar of shareholder equity. Against the prior quarter it is up 286.4 percentage points.

Capital Allocation

R&D Spending
$16.8M
YoY+37.7%
QoQ+15.9%
5Y CAGR+21.1%

Arteris, Inc. invested $16.8M in research and development in Q2 2026. This represents an increase of 37.7% from the same quarter a year earlier. Against the prior quarter it is up 15.9%.

Capital Expenditures
$595K
YoY+67.6%
QoQ+101.7%
5Y CAGR+13.2%

Arteris, Inc. invested $595K in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 67.6% from the same quarter a year earlier. Against the prior quarter it is up 101.7%.

Share Buybacks

Not reported for Q2 2026.

AIP Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AIP quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$24.1M+46.2%$22.9M+38.7%$20.1M+30.0%$17.4M+18.3%$16.5M+13.2%$16.5M+27.7%$15.5M+23.9%$14.7M+10.8%
Cost of Revenue$3.6M+107.1%$3.3M+113.0%$1.9M+18.2%$1.8M+20.9%$1.7M+19.5%$1.5M+4.0%$1.6M+8.8%$1.5M+14.1%
Gross Profit$20.5M+39.1%$19.7M+31.2%$18.3M+31.3%$15.6M+18.0%$14.8M+12.5%$15.0M+30.7%$13.9M+25.9%$13.3M+10.5%
R&D Expenses$16.8M+37.7%$14.5M+21.9%$13.2M+14.7%$12.6M+6.1%$12.2M+13.6%$11.9M+9.5%$11.5M+8.1%$11.9M+8.4%
SG&A Expenses$6.1M+34.9%$5.4M+25.3%$6.4M+56.5%$4.9M+13.3%$4.5M-6.8%$4.3M0.0%$4.1M-10.7%$4.3M-3.2%
Operating Income-$13.9M-68.6%-$9.3M-20.7%-$8.5M-19.2%-$8.7M-10.0%-$8.2M-10.8%-$7.7M+15.6%-$7.1M+23.2%-$7.9M+6.3%
EBITDA-$12.4M-67.4%-$8.0M-15.9%-$7.6M-22.7%-$7.9M-11.3%-$7.4M-11.4%-$6.9M+17.3%-$6.2M+26.2%-$7.1M+5.5%
Interest Expense$30K-70.0%$38K-62.0%-$56K+26.3%$49K-51.0%$100K0.0%$100K+31.6%-$76K-201.3%$100K+29.9%
Income Tax$697K-17.6%-$3.7M-1479.9%-$19K-101.5%$380K+513.0%$846K-13.2%$268K-27.6%$1.2M+1.9%-$92K+76.9%
Net Income-$14.1M-54.1%-$8.0M+2.0%-$8.5M-3.7%-$9.0M-17.0%-$9.1M-9.4%-$8.1M+13.6%-$8.2M+22.2%-$7.7M+5.7%
EPS (Basic)-$0.30-36.4%-$0.17+15.0%-$0.19+5.0%-$0.21-5.0%-$0.220.0%-$0.20+20.0%-$0.20+28.6%-$0.20+13.0%
EPS (Diluted)-$0.30-36.4%-$0.17+15.0%-$0.19+5.0%-$0.21-5.0%-$0.220.0%-$0.20+20.0%-$0.20+28.6%-$0.20+13.0%
Diluted Shares (Avg)47M+13.0%46M+11.5%N/A43M+8.8%42M+8.7%41M+8.3%N/A39M+9.1%

AIP Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AIP quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$224.7M+110.2%$139.9M+42.3%$115.0M+8.4%$107.7M+10.3%$106.9M+10.9%$98.3M-3.0%$106.1M+3.2%$97.7M-4.4%
Current Assets$146.3M+137.8%$61.5M+7.2%$82.4M+19.3%$61.0M-2.8%$61.5M+4.5%$57.4M-7.1%$69.1M+18.2%$62.8M+1.3%
Cash & Equivalents$93.3M+479.3%$11.7M-28.7%$33.9M+147.7%$17.4M-2.3%$16.1M-27.2%$16.4M-37.3%$13.7M-0.1%$17.8M-4.3%
Short-Term Investments$28.8M+31.7%$26.4M+1.9%$20.7M-31.4%$21.6M-30.1%$21.9M-7.5%$25.9M+38.8%$30.2M+9.8%$30.8M+11.2%
Accounts Receivable$15.2M-18.8%$14.7M+43.1%$19.2M-6.9%$16.5M+89.1%$18.8M+109.6%$10.3M-16.3%$20.6M+71.7%$8.7M-16.0%
Long-Term Investments$1.2M-92.5%$3.8M-70.4%$4.9M-41.8%$17.2M+195.2%$15.9M+95.8%$12.8M+48.6%$8.5M-27.9%$5.8M-43.2%
Goodwill$35.3M+744.9%$35.2M+742.4%$4.2M0.0%$4.2M0.0%$4.2M0.0%$4.2M0.0%$4.2M0.0%$4.2M0.0%
Total Liabilities$157.0M+37.3%$137.3M+33.1%$129.7M+20.8%$119.2M+24.8%$114.4M+25.6%$103.1M+12.3%$107.3M+22.4%$95.5M+19.2%
Current Liabilities$93.3M+49.2%$84.5M+49.5%$73.2M+23.5%$66.8M+23.2%$62.6M+20.9%$56.5M+13.5%$59.3M+27.8%$54.2M+21.8%
Non-Current Liabilities$63.7M+22.8%$52.8M+13.2%$56.5M+17.5%$52.4M+26.9%$51.9M+31.7%$46.6M+11.0%$48.0M+16.3%$41.3M+15.9%
Total Equity$67.7M+998.8%$2.6M+153.7%-$14.6M-1131.6%-$11.4M-618.3%-$7.5M-242.7%-$4.8M-150.5%-$1.2M-107.9%$2.2M-90.0%
Retained Earnings-$193.7M-25.6%-$179.6M-23.9%-$171.6M-25.4%-$163.1M-26.8%-$154.1M-27.4%-$145.0M-28.7%-$136.9M-32.6%-$128.7M-38.8%

Not reported in any period shown, so not listed: Inventory, Long-Term Debt.

AIP Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AIP quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow$9.2M+470.6%-$7.1M-346.9%$3.2M+220.5%$3.2M+183.9%-$2.5M-899.0%$2.9M+499.6%-$2.6M+11.7%$1.1M+140.0%
Depreciation & Amortization$1.5M+79.3%$1.3M+59.5%$844K-5.0%$843K-0.1%$845K+6.0%$844K+1.3%$888K+7.1%$844K-12.5%
Stock-Based Compensation$6.3M+41.1%$5.5M+27.8%N/A$5.0M+12.9%$4.5M+19.6%$4.3M+17.9%N/A$4.4M+18.2%
Capital Expenditures$595K+67.6%$295K+61.2%$134K+168.0%$716K+2209.7%$355K+655.3%$183K-6.6%$50K-88.3%$31K-90.9%
Free Cash Flow$8.6M+403.3%-$7.4M-374.8%$3.0M+213.2%$2.5M+126.4%-$2.8M-1175.8%$2.7M+852.7%-$2.7M+21.3%$1.1M+134.7%
Investing Cash Flow-$372K-152.8%-$16.0M-13162.8%$13.1M+778.2%-$1.6M+64.9%$705K+116.2%-$121K-101.0%-$1.9M-40.9%-$4.6M-25.8%
Financing Cash Flow$72.8M+4724.7%$882K+1796.2%$142K-65.7%-$181K+76.6%$1.5M+2641.8%-$52K-218.2%$414K+170.9%-$775K+35.8%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

AIP Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AIP quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Gross Margin85.0%-4.4pp85.8%-4.9pp90.8%+0.9pp89.9%-0.2pp89.4%-0.6pp90.8%+2.1pp89.8%+1.4pp90.1%-0.3pp
Operating Margin-57.6%-7.7pp-40.6%+6.1pp-42.0%+3.8pp-50.1%+3.8pp-50.0%+1.1pp-46.6%+23.9pp-45.9%+28.1pp-53.8%+9.9pp
Net Margin-58.3%-2.9pp-34.7%+14.4pp-42.2%+10.7pp-51.6%+0.6pp-55.3%+1.9pp-49.1%+23.5pp-53.0%+31.3pp-52.3%+9.2pp
Return on Equity-20.8%-307.2%N/AN/AN/AN/AN/A-348.0%-311.0pp
Return on Assets-6.3%+2.3pp-5.7%+2.6pp-7.4%+0.3pp-8.3%-0.5pp-8.5%+0.1pp-8.3%+1.0pp-7.7%+2.5pp-7.9%+0.1pp
Current Ratio1.57+0.6x0.73-0.3x1.130.0x0.91-0.2x0.98-0.2x1.02-0.2x1.17-0.1x1.16-0.2x
Debt-to-Equity2.3252.99N/AN/AN/AN/AN/A43.23+39.6x
Asset Turnover0.110.0x0.160.0x0.180.0x0.160.0x0.150.0x0.170.0x0.150.0x0.150.0x
FCF Margin35.7%+52.9pp-32.1%-48.3pp15.1%+32.4pp14.2%+6.8pp-17.2%-19.0pp16.2%+14.0pp-17.3%+9.9pp7.4%+31.1pp

Note: Shareholder equity is negative (-$14.6M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Arteris, Inc. AIP FY2025 $70.6M -$34.7M -49.2% $1.2B 68/100
SEALSQ Corp LAES FY2025 $18.3M -$34.2M N/A $533.1M 45/100
POET Technologies Inc. POET FY2025 $1.1M -$63.0M N/A $1.3B 19/100
NVE Corp NVEC FY2026 $26.3M $15.2M 57.7% $539.0M 82/100
CEVA Inc. CEVA FY2025 $109.6M -$10.6M -9.7% $1.0B 74/100
SkyWater Technology, Inc. SKYT FY2025 $442.1M $118.9M 26.9% $1.6B 40/100

Frequently Asked Questions

What is Arteris, Inc.'s annual revenue?

Arteris, Inc. (AIP) reported $70.6M in total revenue for fiscal year 2025. This represents a 22.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Arteris, Inc.'s revenue growing?

Arteris, Inc. (AIP) revenue grew by 22.3% year-over-year, from $57.7M to $70.6M in fiscal year 2025.

Is Arteris, Inc. profitable?

No, Arteris, Inc. (AIP) reported a net income of -$34.7M in fiscal year 2025, with a net profit margin of -49.2%.

Arteris, Inc. (AIP) reported diluted earnings per share of -$0.82 for fiscal year 2025. This represents a 4.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Arteris, Inc. (AIP) had EBITDA of -$29.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Arteris, Inc. (AIP) had a gross margin of 90.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Arteris, Inc. (AIP) had an operating margin of -46.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Arteris, Inc. (AIP) had a net profit margin of -49.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Arteris, Inc. (AIP) generated $5.3M in free cash flow during fiscal year 2025. This represents a 612.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Arteris, Inc. (AIP) generated $6.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Arteris, Inc. (AIP) had $115.0M in total assets as of fiscal year 2025, including both current and long-term assets.

Arteris, Inc. (AIP) invested $1.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Arteris, Inc. (AIP) invested $49.9M in research and development during fiscal year 2025.

Arteris, Inc. (AIP) had 45M shares outstanding as of fiscal year 2025.

Arteris, Inc. (AIP) had a current ratio of 1.13 as of fiscal year 2025, which is considered adequate.

Arteris, Inc. (AIP) had a return on assets of -30.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Arteris, Inc. (AIP) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $1.2B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Arteris, Inc. (AIP) trades at 14.3x sales, its market capitalization divided by revenue of $84.6M revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.2B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Arteris, Inc. (AIP) has negative shareholder equity of -$14.6M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Arteris, Inc. (AIP) has an Altman Z-Score of 3.28, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Arteris, Inc. (AIP) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Arteris, Inc. (AIP) reported a net loss of $34.7M while generating $6.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Arteris, Inc. (AIP) reported an operating loss of $33.1M against $193K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Arteris, Inc. (AIP) scores 68 out of 100 on our Financial Health Score, indicating strong standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top